CDC IXIS Innovation
Overview
CDC IXIS Innovation is a venture capital firm headquartered in Paris, France, with additional offices in Silicon Valley and Geneva. The firm primarily invests between EUR 6 million and EUR 10 million in both early-stage and late-stage companies within the information technology and life sciences sectors. Their investment strategy focuses on supporting innovative firms that demonstrate strong growth potential and align with their expertise in these industries. The firm's portfolio includes a diverse range of companies operating in the information technology and life sciences sectors. By leveraging their extensive network and industry knowledge, CDC IXIS Innovation aims to foster the growth of these companies, contributing to advancements in technology and healthcare. Their approach emphasizes active involvement and strategic guidance to enhance the value and impact of their investments. CDC IXIS Innovation's commitment to innovation and growth is evident through their strategic investments and partnerships. Their focus on sectors such as information technology and life sciences reflects a dedication to supporting industries that drive significant societal and economic progress. Through their investments, they aim to empower companies to achieve their full potential and make meaningful contributions to their respective fields.
Investment Focus
- Innovative business models
- Strong growth potential
- Alignment with firm's expertise in information technology and life sciences
Reach CDC IXIS Innovation directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about CDC IXIS Innovation
What sectors does CDC IXIS Innovation invest in?
CDC IXIS Innovation invests in Life Sciences and Information Technology, and is based in Île-De-France, France. CDC IXIS Innovation is listed as a venture capital in the ConnectSafely investor database.
What stage does CDC IXIS Innovation invest at?
CDC IXIS Innovation backs companies at Early Stage and Late Stage, writing cheques of 6M - 10M.
Which regions does CDC IXIS Innovation invest in?
CDC IXIS Innovation invests across United States, France and Switzerland.
Last updated · Source: ConnectSafely investor database
